Physician profile
Dharmik Patel
NPI 1982354866
$588.11
in general payments reported to CMS, 2019-2025
13 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.86 · 2023: $14.80 · 2024: $304 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $102.47 | 2024 | Opdivo |
| Abbvie INC. | $93.03 | 2024 | |
| Genentech USA, INC. | $76.45 | 2025 | Venclexta, Itovebi, Polivy |
| Regeneron Healthcare Solutions, INC. | $67.67 | 2024-2025 | Libtayo, Lynozyfic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.90 | 2022-2024 | Xifaxan |
| Inspire Medical Systems, INC. | $35.29 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $33.29 | 2025 | Iclusig |
| Merck Sharp & Dohme LLC | $25.60 | 2025 | Welireg, Keytruda |
| Caris Mpi, INC. | $25.43 | 2025 | Mi Cancer Seek |
| Pfizer INC. | $24.21 | 2025 | |
| Alexion Pharmaceuticals, INC. | $23.34 | 2025 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $19.63 | 2025 | |
| Inari Medical, INC. | $14.80 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dharmik Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.